Related Experiment Video
Updated: Jul 7, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Mutations in the RUNX2 gene in Chinese patients with cleidocranial dysplasia
Dongying Xuan1, Shi Li, Xiong Zhang
1Department of Periodontology, Guangdong Provincial Stomatological Hospital, Southern Medical University, S366 Jiangnan Boulevard, Guangzhou, 510280, China.
Abstract:
Cleidocranial dysplasia (CCD) is an autosomal dominant inheritable skeletal disease caused by heterozygous mutations in an osteoblast-specific transcription factor, RUNX2. Mutational analyses of RUNX2 were done on 4 unrelated Chinese patients with CCD. One nonsense and 3 missense mutations were detected, including one novel mutation, a heterozygous G to C transition mutation at nucleotide 475 in exon 2, which converts glycine to arginine at codon 159 (G159R). Two mutations, R225W and R391X, were reported in Chinese patients with CCD for the first time. Our findings show that R225 mutations interfere with nuclear accumulation of RUNX2 protein, and that a lack of nuclear RUNX2 protein accumulation is at least one of the causes of haploinsufficiency in these cases. Body stature was significantly reduced in the 3 male and 1 female cases. The cases all had malformations of the tarsometatarsal joints. In 1 case, the humeroulnar joints and humeroradial joints were abnormal, and the elbow looked like a triangle. The data suggest that an impaired runt domain contributes to the short stature of CCD patients. We postulate that RUNX2 influences joint formation by affecting the differentiation pathways of chondrocytes and osteoblasts.
Insights
Cleidocranial dysplasia (CCD) is a genetic disorder caused by RUNX2 gene mutations. This study identified new mutations in Chinese CCD patients, linking RUNX2 dysfunction to short stature and joint malformations.
Area of Science:
- Genetics
- Molecular Biology
- Orthopedics
Background:
- Cleidocranial dysplasia (CCD) is an autosomal dominant skeletal disorder.
- It stems from heterozygous mutations in the RUNX2 gene, an osteoblast-specific transcription factor.
Purpose of the Study:
- To investigate RUNX2 mutations in four unrelated Chinese patients with CCD.
- To understand the molecular mechanisms underlying CCD pathogenesis and clinical manifestations.
Main Methods:
- Mutational analysis of the RUNX2 gene.
- Correlation of genotype with clinical phenotypes, including skeletal malformations and stature.
Main Results:
- Identified four RUNX2 mutations in Chinese CCD patients: one novel (G159R) and three previously reported (R225W, R391X).
- Demonstrated that R225 mutations impede RUNX2 nuclear accumulation, contributing to haploinsufficiency.
- Observed significantly reduced body stature and tarsometatarsal joint malformations in all cases.
Conclusions:
- RUNX2 mutations are a cause of CCD in the Chinese population.
- Impaired RUNX2 nuclear accumulation and function contribute to short stature and skeletal abnormalities in CCD.
- RUNX2 likely plays a role in chondrocyte and osteoblast differentiation, influencing joint development.
Related Concept Videos
Pleiotropy
Sex-linked Disorders
X-linked Traits
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

